美敦力宣布收购Spr Therapeutics,拓展慢性疼痛患者治疗选择

美股速递
May 20

医疗科技巨头美敦力宣布,计划收购Spr Therapeutics公司。此举旨在进一步拓宽慢性疼痛患者的治疗路径与选择范围。通过整合Spr在疼痛管理领域的创新技术,美敦力将强化其产品组合,为深受慢性疼痛困扰的人群提供更多样化的解决方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10